Product
BNC
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
Phase I, Double-Blind, Placebo-Controlled, Ascending, Single-Dose, Safety, Tolerability and Pharmacokinetic Study of Bisnorcymserine (BNC), a Highly Selective Inhibitor of Butyrylcholinesterase, in Healthy Adult VolunteersStatus: Completed, Estimated PCD: 2018-09-21